Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)
Hear professionals discuss diagnosing tardive dyskinesia and treatment. AUSTEDO can cause serious side effects in people with Huntington’s disease, including: depression, suicidal thoughts, or suicidal …
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine ...
The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia. Adverse reactions …
Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Aug 20, 2025 · Austedo (deutetrabenazine) is a prescription medicine used to treat chorea associated with Huntington's disease and tardive dyskinesia (TD), which are involuntary movement disorders.
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...
Nov 7, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia. …
OTC Dynamics | $TEVA Teva Announces AUSTEDO® XR ...
About AUSTEDO XR Extended-Release Tablets and AUSTEDO Tablets AUSTEDO XR and AUSTEDO are the first vesicular monoamine transporter 2 (VMAT2) inhibitors approved by the U.S. Food and …
Austedo: Dosage, side effects, alternatives, and more
Jan 29, 2025 · Austedo (deutetrabenazine) is a brand-name prescription drug that’s used for certain movement disorders. Learn about side effects, warnings, dosage, and more.
What to Expect During AUSTEDO XR® Treatment
Once your healthcare provider prescribes AUSTEDO XR® to help treat your Tardive Dyskinesia (TD), it’s important to know what to expect. The timeline below provides an overview of the stages of a …
Treatments – National Organization for Tardive Dyskinesia
While the recommendations in the above table can prove effective for many individuals with TD, there have been numerous additional treatments studied to determine their effectiveness in treating TD. A …
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...
Dec 2, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia.
Austedo XR: FDA Approved for tardive Dyskinesia
Jun 1, 2024 · In a significant advancement for those suffering from tardive dyskinesia (TD), the U.S. Food and Drug Administration (FDA) recently approved Austedo XR (extended-release …